Sangamo Therapeutics Reports Recent Business Highlights and First Quarter 2026 Financial Results

Click here to view

Presentation

Durable, Multiplexed Cell Engineering Using Zinc Finger–Guided Transcriptional Regulators Delivered via a Single Viral Particle

Download PDF